USP <61> and <62> Microbiology Testing for Herbal Raw Materials: Why Total Yeast and Mold Counts Catch What Visual Inspection Misses

A pound of ashwagandha root powder can arrive in Countryside, IL with a perfectly intact seal, a mild earthy smell, and a certificate of analysis showing a Total Aerobic Microbial Count (TAMC) of 48,000 CFU/g — comfortably within the USP limit of 100,000 CFU/g for oral non-aqueous preparations. What that supplier COA often won’t tell you is the Total Yeast and Mold Count (TYMC), the absence-of-Salmonella result, or whether the plating method used was appropriate for an antimicrobial botanical matrix.

We’ve seen this scenario more times than I care to count. A Midwest supplement brand passes incoming raw material inspection based on visual checks and a supplier-provided document, manufactures 30,000 bottles, and then watches a third-party audit or retail compliance test come back with a TYMC failure at 8,400 CFU/g — more than eight times the 1,000 CFU/g acceptance criterion for oral-use botanicals under USP General Chapter <61>.

The problem isn’t negligence. It’s a fundamental misunderstanding of what USP <61> and <62> are designed to catch, and what a qualified analytical testing laboratory protocol actually requires.

---

What USP <61> and <62> Actually Measure (and Where Brands Misread the Acceptance Criteria)

USP General Chapter <61> covers Microbial Enumeration Tests — specifically Total Aerobic Microbial Count (TAMC) and Total Yeast and Mold Count (TYMC). USP <62> covers Tests for Specified Organisms: Salmonella species, Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, and bile-tolerant gram-negative bacteria.

The acceptance criteria that matter most for herbal raw materials appear in USP <1111> (Microbiological Examination of Nonsterile Products: Acceptance Criteria for Pharmaceutical Preparations and Substances for Pharmaceutical Use). For oral non-aqueous preparations — which covers virtually every encapsulated or tableted botanical supplement — the hard limits are:

• TAMC: ≤ 10⁵ CFU/g (100,000 CFU/g)
• TYMC: ≤ 10³ CFU/g (1,000 CFU/g)
• Specified organisms: Absence of Salmonella per 25 g; ≤ 10³ CFU/g for E. coli; absence of S. aureus and P. aeruginosa per 1 g

Notice the difference in scale. The TYMC limit is 100 times tighter than the TAMC limit. That asymmetry catches brands off guard constantly. A TAMC of 50,000 CFU/g looks fine on a quick review. A TYMC of 2,300 CFU/g on the same sample is a hard fail — one that the supplier’s COA may never have flagged because not all overseas labs run the TYMC as a matter of routine.

The other common error is applying the wrong acceptance category. A brand that treats raw botanical ingredients destined for oral capsules as if they were Category 3 (aqueous, topical) preparations is operating against the wrong limit entirely. Misapplied criteria don’t protect you in an FDA 21 CFR Part 111 audit; they just mean your documentation is wrong in a different direction.

---

Why Botanical Raw Materials Are a Microbiological Minefield

Roots, leaves, bark, and seeds accumulate environmental microorganisms during growth, harvest, drying, and transit. Ground botanical powders have dramatically higher surface area than whole plant material — more exposed surface means more microbial attachment sites and faster proliferation if moisture enters during storage or shipping. A lot that tests clean at origin can arrive with elevated counts after three weeks in a container on water.

Several botanical ingredients are routinely problematic at incoming testing:

• Licorice root (Glycyrrhiza glabra): High sugar content feeds yeast and mold growth; TYMC failures are common in warm-weather shipments arriving in summer.
• Valerian root (Valeriana officinalis): Moisture-sensitive; poorly dried lots regularly arrive with mold counts exceeding 5,000 CFU/g.
• Ashwagandha root (Withania somnifera): TAMC frequently runs between 20,000–80,000 CFU/g in standard commercial lots. The risk is when TYMC begins climbing alongside it, which happens when storage humidity exceeded 65% RH at any point in the supply chain.
• Eleuthero root (Eleutherococcus senticosus): Bacterial count variability is wide; some shipments from certain Asian origins carry detectable E. coli at levels that trigger USP <62> failures.
• Mushroom powders (reishi, lion’s mane, chaga): Naturally high TYMC because mushrooms are fungi — the USP acceptance criteria don’t change on account of the ingredient’s nature, which means tighter sourcing discipline applies.

None of this means these ingredients are inherently unsafe to use. But it does mean that a lot-release decision made on a supplier COA rather than independent USP <61>/<62> testing carries real product liability exposure. Under 21 CFR Part 111 §111.75, dietary supplement manufacturers are required to collect and test a representative sample of each incoming component — or have a documented, validated process that ensures no lots are skipped. The FDA has issued Warning Letters citing this requirement to supplement brands across the Midwest, and it remains one of the most common cGMP deficiencies observed during establishment inspections.

---

The Antimicrobial Matrix Problem: Why Standard Protocols Can Produce False Negatives

Here’s something that doesn’t show up in most supplier qualification guides: certain botanical raw materials have inherent antimicrobial properties that suppress microbial growth directly in the culture medium.

Oregano extract, cinnamon bark powder, clove bud extract, and thyme contain phenolic compounds — thymol, carvacrol, eugenol — that inhibit the same microorganisms you’re trying to detect. If you inoculate an aqueous suspension of cinnamon bark powder onto standard Tryptic Soy Agar without first neutralizing those inhibitors, you may see artifactually low colony counts. That’s a false negative — and in microbiology testing, a false negative is worse than no test at all, because it produces false confidence.

USP <61> addresses this directly. The chapter requires a Method Suitability Test (MST) to confirm that the laboratory’s procedure can detect organisms in the specific matrix being tested. The MST introduces known quantities of challenge organisms — Aspergillus brasiliensis, Candida albicans, Bacillus subtilis, Staphylococcus aureus, Pseudomonas aeruginosa, and Candida albicans for TYMC — into the test article at known concentrations, then verifies that recovery meets ≥ 70% of the positive control count. If recovery fails, the method must be modified: typically through matrix dilution, pH adjustment, or the addition of neutralizing agents such as polysorbate 80 or lecithin.

The practical implication: if your supplier is running a standard USP <61> protocol without a validated MST for cinnamon, oregano, or similar high-phenolic botanicals, their TYMC and TAMC results may be systematically underreported. This isn’t always intentional — many overseas labs apply a generic method across all raw materials and never validate against specific matrices. But as the manufacturer, you own the compliance burden under DSHEA. The FDA doesn’t care whose lab made the error.

---

What a 21 CFR Part 111–Compliant Incoming Microbiology Program Actually Looks Like

For supplement brands operating in the Chicago metro — whether you’re a contract manufacturer in Westmont, a private-label operation in Naperville, or a startup finishing product near O’Hare — a defensible incoming raw material microbiology program requires four elements that must be present and documented:

1. Identity before microbiology. 21 CFR Part 111 §111.75(a)(1) requires identity confirmation before any other component testing. Running USP <61>/<62> on a material you haven’t confirmed is what you ordered is a sequencing error that will surface in any competent audit. Botanical identity testing — HPTLC, DNA barcoding, or at minimum organoleptic plus TLC — must precede microbiological release.

2. Representative sampling. Composite sampling from multiple positions within each container using a grain thief sampler isn’t optional — it’s the difference between testing the surface of a 50 kg drum and testing the actual lot. A surface scoop is not representative sampling.

3. Method-validated USP <61>/<62> from an ISO 17025–accredited analytical testing laboratory. ISO 17025 accreditation requires the laboratory to maintain proficiency testing, validate analytical methods formally, and demonstrate traceability of results. A Certificate of Analysis from an accredited facility carries a legally defensible standard of data integrity that unaccredited testing simply cannot match.

4. Formal lot disposition before use. No botanical raw material should enter production until the lot is released against documented written acceptance criteria. For botanical ingredients specifically, that means waiting on the TYMC result — not just TAMC — and including Salmonella absence data for root materials sourced from South Asia or Latin America, where environmental Salmonella prevalence is measurably higher.

A full USP <61>/<62> test with Method Suitability testing typically turns around in 5–7 business days at an ISO 17025–accredited laboratory. For brands shipping samples through our Chicago-area receiving facility in Countryside, IL, that clock starts from the day we sign for your sample.

---

The TYMC–Mycotoxin Connection Most Brands Overlook

A TYMC failure isn’t only a compliance problem. High yeast and mold counts in botanical raw materials — particularly roots, grains, and dried fruits — raise a downstream question that USP <61>/<62> is not equipped to answer: are any of those molds mycotoxin-producing strains?

Aflatoxins B1, B2, G1, and G2 are produced primarily by Aspergillus flavus and A. parasiticus. Ochratoxin A is produced by A. ochraceus and Penicillium verrucosum. The European Union sets maximum levels of 4 μg/kg for aflatoxin B1 and 10 μg/kg for total aflatoxins in herbal preparations. While the US FDA hasn’t established mandatory federal dietary supplement mycotoxin limits, the agency has issued import alerts for aflatoxin-contaminated botanicals — and major US retailers, including Amazon, are increasingly requiring mycotoxin screens as part of brand qualification programs.

A practical trigger rule: if a botanical raw material arrives with TYMC above 500 CFU/g, treat it as a flag for additional mycotoxin screening. USP <61>/<62> is your first filter; mycotoxin testing by LC-MS/MS is the second layer. The two tests together cost far less than a product recall.

---

Start With the Test Your Supplier Skipped

Most botanical raw material contamination events are preventable. They trace back to a single moment in the supply chain when someone accepted a document instead of running a test. The lot that fails your retail partner’s third-party audit was almost certainly the same lot that looked fine on paper six months earlier.

Establish a written incoming testing protocol that mandates USP <61>/<62> — with Method Suitability validation, representative sampling, and formal lot disposition — before any botanical raw material reaches your production floor. Sequence identity first. Know your TYMC, not just your TAMC. And make sure your analytical testing laboratory has actually validated their method against your specific ingredients, not just against a generic water blank.

Those four steps will keep you on the right side of a 21 CFR Part 111 audit and off the short list for the next retail compliance sweep.

---

Written by Nour Abochama, VP Operations, Qalitex | Quality Consultant, Ayah Labs. Learn more about our team

Ship your sample to our Chicago facility — get a Qalitex CoA in 5–7 days. Contact us

Related from our network

• ISO 17025–accredited supplement testing and raw material CoA services — Qalitex Laboratories provides the analytical infrastructure behind every Ayah Labs test report, from ICP-MS heavy metals to full USP <61>/<62> microbiology panels.